-
News Summary
Wednesday, January 26, 2011 - 10:35am | 233Shares of ConocoPhillips (NYSE: COP) gained about 0.4% after the company reported 54% y/y rise in its Q4 profit. The company's profit came in at $1.39 per share, versus $0.86 per share, in the year-ago quarter. The company's adjusted earnings increased to $1.32 per share from $1.20 per share. COP...
-
Company News for January 26, 2011 - Corporate Summary
Wednesday, January 26, 2011 - 10:31am | 872• Stryker (NYSE:SYK) reported Q4 EPS of $0.93, ahead of the Zack Consensus Estimate of $0.89 per share. Revenues for the quarter rose 8.6% to $2.0 billion, well above the Zack Consensus Estimate of $1.970 billion • Yahoo (NASDAQ:YHOO) reported Q4 EPS of $0.26, ex-items, topping Zack Consensus...
-
Stock Market News for Jan 26, 2011 - Market News
Wednesday, January 26, 2011 - 10:31am | 1483Markets closed almost flat yesterday after erasing losses ahead of President Obama's State of Union speech, scheduled for later in the day. Late-day buying helped the markets gained slightly before the close. On Tuesday, the markets closed almost flat after erasing early losses due to...
-
Stryker Beats but Concerns Linger - Analyst Blog
Wednesday, January 26, 2011 - 10:31am | 1362Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33...
-
Abbott Labs Tops 4Q Estimates - Analyst Blog
Wednesday, January 26, 2011 - 10:29am | 898Abbott Laboratories (ABT) reported fourth quarter earnings of $1.30 per share, a penny above the Zacks Consensus Estimate and within the guidance range provided by the company. Earnings increased 10.2% from the year-ago period. Higher revenues helped drive results. However, including one-time...
-
Stryker Beats but Concerns Linger - Analyst Blog
Wednesday, January 26, 2011 - 10:15am | 1362Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33...
-
Stock Market News for Jan 26, 2011 - Market News
Wednesday, January 26, 2011 - 10:09am | 1483Markets closed almost flat yesterday after erasing losses ahead of President Obama's State of Union speech, scheduled for later in the day. Late-day buying helped the markets gained slightly before the close. On Tuesday, the markets closed almost flat after erasing early losses due to...
-
Company News for January 26, 2011 - Corporate Summary
Wednesday, January 26, 2011 - 10:09am | 872• Stryker (NYSE:SYK) reported Q4 EPS of $0.93, ahead of the Zack Consensus Estimate of $0.89 per share. Revenues for the quarter rose 8.6% to $2.0 billion, well above the Zack Consensus Estimate of $1.970 billion • Yahoo (NASDAQ:YHOO) reported Q4 EPS of $0.26, ex-items, topping Zack Consensus...
-
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Wednesday, January 26, 2011 - 10:08am | 487Merck KGaA (MKGAF) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) upheld its negative recommendation related to the approval of cladribine for the treatment of relapsing-remitting multiple sclerosis (MS). In September last year,...
-
Decent Quarter for Dr. Reddy's - Analyst Blog
Wednesday, January 26, 2011 - 10:08am | 567Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2011 earnings per American Depository Share (ADS) of 40 cents compared with a loss per ADS of 70 cents in the year-ago period. Higher revenues helped boost earnings. Revenues The company reported quarterly revenues of $424 million,...
-
Abbott Laboratories Profit Down 6% To $1.44 Billion (ABT)
Wednesday, January 26, 2011 - 9:51am | 232Abbott Park, Illinois-based Abbott Laboratories (NYSE: ABT) released financial results on Wednesday morning that just beat Wall Street estimates. Abbott Laboratories announced that its 4th quarter net earnings fell 6.4% to $1.44 billion, or 92 cents per share, down from $1.54 billion, or 98 cents...
-
Decent Quarter for Dr. Reddy's - Analyst Blog
Wednesday, January 26, 2011 - 9:30am | 567Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2011 earnings per American Depository Share (ADS) of 40 cents compared with a loss per ADS of 70 cents in the year-ago period. Higher revenues helped boost earnings. Revenues The company reported quarterly revenues of $424 million,...
-
A Peek Into The Market Before The Trading Starts
Wednesday, January 26, 2011 - 9:26am | 449Pre-open movers US stock futures are higher this morning, following President Barack Obama's State of the Union speech. Investors are awaiting earnings reports and monetary policy announcement by the Federal Reserve. Futures on the Dow Jones Industrial Average gained 31 points to 11,953 and S&P...
-
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Wednesday, January 26, 2011 - 9:15am | 487Merck KGaA (MKGAF) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) upheld its negative recommendation related to the approval of cladribine for the treatment of relapsing-remitting multiple sclerosis (MS). In September last year,...
-
Teva and APP Announce Launch of Generic Gemzar
Wednesday, January 26, 2011 - 9:13am | 88Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and APP Pharmaceuticals, Inc. announced today the commercial launch of Gemcitabine HCI for Injection in 200 mg and 1 g single dose vials, the generic version of Gemzar, in the United States, pursuant to a commercialization, manufacture and supply...